HRH3 and early-onset autosomal dominant Alzheimer disease: There is evidence for histamine H3 receptor dysregulation in several diseases, including Alzheimer's disease and vascular dementia where a negative correlation between fronto-cortical H3 receptor density and cognitive decline exists [7], [8].